By now you’ve heard about the newest and first medication specifically to prevent migraine. Aimovig™ was approved by the United States Food and Drug Administration (FDA) on May 17, 2018. As written on their website, Aimovig is “the first and only FDA-approved therapy specifically designed to help prevent migraine in adults by targeting and blocking the calcitonin gene-related peptide receptor (CGRP-R).” In this article you will learn what you, as a person with migraine, or your caregiver will need to do to apply for the Aimovig™ monthly injection and get your first two doses FREE if you do not have insurance or have a government sponsored health plan, like Medicaid.
